UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

(110) Management of Intractable Psychosis in a Patient with Hereditary Aceruloplasminemia-associated Neurodegeneration: The Role of Electroconvulsive Therapy

Journal of the Academy of Consultation-Liaison Psychiatry, 2023-11, Vol.64, p.S54

2023

Volltextzugriff (PDF)

Abstract 1695: Development of a novel antibody-drug conjugate for the treatment of c-Kit expressing solid tumors and AML

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1695-1695

2015

Volltextzugriff (PDF)

Abstract 2648: L-arginine regulates chemotherapy sensitivity via ER stress and autophagic pathways in arginine prototrophic cancer cells

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2648-2648

2020

Volltextzugriff (PDF)

Abstract 2671: INCB050465, a novel PI3Kδ inhibitor, synergizes with PIM protein kinase inhibition to cause tumor regression in a model of DLBCL

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2671-2671

2015

Volltextzugriff (PDF)

Abstract 4207: JAK inhibition reverses IL10-mediated resistance to B cell receptor (BCR) pathway inhibition in DLBCL

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4207-4207

2014

Volltextzugriff (PDF)

Abstract 4531: INCB40093 is a selective PI3Kδ inhibitor with potent antiproliferative activity against human B-cell tumors

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4531-4531

2014

Volltextzugriff (PDF)

Abstract 5162: Discovery of INCB098377: a potent inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5162-5162

2023

Volltextzugriff (PDF)

Abstract 5397: Characterization of INCB053914, a novel pan-PIM kinase inhibitor

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5397-5397

2015

Volltextzugriff (PDF)

Abstract 5414: Activity of the pan-PIM kinase inhibitor INCB053914 in models of multiple myeloma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5414-5414

2015

Volltextzugriff (PDF)

Abstract 5416: Activity of the pan-PIM kinase inhibitor INCB053914 in models of acute myelogenous leukemia

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5416-5416

2015

Volltextzugriff (PDF)

Abstract C106: Discovery and characterization of INCB024360, a potent and selective inhibitor of indoleamine 2,3-dioxygenase (IDO1) as a novel agent for cancer immunotherapy

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.C106-C106

2009

Volltextzugriff (PDF)

Brain or Mind?

Streams of Consciousness, 2019-07, Vol.2 (2), p.e1045

Niu, Kathy

2019

Volltextzugriff (PDF)

BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non-small Cell Lung Carcinoma In Vitro

Journal of thoracic oncology, 2011-11, Vol.6 (11), p.1801-1809

2011

Volltextzugriff (PDF)

Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey

Drug design, development and therapy, 2019-10, p.3705

2019

Volltextzugriff (PDF)

Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy: A 10-year Fabry Outcome Survey analysis

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S98-S98

2016

Volltextzugriff (PDF)

Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis

Drug design, development and therapy, 2019-01, Vol.13, p.3705-3715

2019

Volltextzugriff (PDF)

Case 26-2020: A Woman with Altered Mental Status and Left-Sided Weakness

The New England journal of medicine, 2021-01, Vol.384 (1), p.92-92

2021

Volltextzugriff (PDF)

Clinical Neuroscience Continuing Education for Psychiatrists

Academic psychiatry, 2023-06, Vol.47 (3), p.297-303

2023

Volltextzugriff (PDF)

Combining hook length formulas and BG-ranks for partitions via the Littlewood decomposition

Transactions of the American Mathematical Society, 2011-02, Vol.363 (2), p.1041-1060

2011

Volltextzugriff (PDF)

Culturally Confounded Diagnostic Dilemmas: When Religion and Psychosis Intersect

Harvard review of psychiatry, 2019-05, Vol.27 (3), p.201-208

2019

Volltextzugriff (PDF)

Deregulation of miRNAs suggest the activation of a neuronal protective mechanism during preclinical stages of prion disease

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P172-P172

2012

Volltextzugriff (PDF)

The diagnostic criteria and structure of catatonia

Schizophrenia research, 2015-05, Vol.164 (1), p.256-262

2015

Volltextzugriff (PDF)

Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice

PLoS pathogens, 2012-11, Vol.8 (11), p.e1003002-e1003002

2012

Volltextzugriff (PDF)

Electroconvulsive Therapy in Managing Intractable Psychosis in Hereditary Aceruloplasminemia-Associated Neurodegeneration: A Case Report

Journal of the Academy of Consultation-Liaison Psychiatry, 2024-07

2024

Volltextzugriff (PDF)

Fabry Outcome Survey (FOS): Highlights from a 20-year patient registry of Fabry disease

Molecular genetics and metabolism, 2021-02, Vol.132 (2), p.S19-S19

2021

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

(110) Management of Intractable Psychosis in a Patient with Hereditary Aceruloplasminemia-associated Neurodegeneration: The Role of Electroconvulsive Therapy

Abstract 1695: Development of a novel antibody-drug conjugate for the treatment of c-Kit expressing solid tumors and AML

Abstract 2648: L-arginine regulates chemotherapy sensitivity via ER stress and autophagic pathways in arginine prototrophic cancer cells

Abstract 2671: INCB050465, a novel PI3Kδ inhibitor, synergizes with PIM protein kinase inhibition to cause tumor regression in a model of DLBCL

Abstract 4207: JAK inhibition reverses IL10-mediated resistance to B cell receptor (BCR) pathway inhibition in DLBCL

Abstract 4531: INCB40093 is a selective PI3Kδ inhibitor with potent antiproliferative activity against human B-cell tumors

Abstract 5162: Discovery of INCB098377: a potent inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ)

Abstract 5397: Characterization of INCB053914, a novel pan-PIM kinase inhibitor

Abstract 5414: Activity of the pan-PIM kinase inhibitor INCB053914 in models of multiple myeloma

Abstract 5416: Activity of the pan-PIM kinase inhibitor INCB053914 in models of acute myelogenous leukemia

Abstract C106: Discovery and characterization of INCB024360, a potent and selective inhibitor of indoleamine 2,3-dioxygenase (IDO1) as a novel agent for cancer immunotherapy

Brain or Mind?

BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non-small Cell Lung Carcinoma In Vitro

Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey

Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy: A 10-year Fabry Outcome Survey analysis

Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis

Case 26-2020: A Woman with Altered Mental Status and Left-Sided Weakness

Clinical Neuroscience Continuing Education for Psychiatrists

Combining hook length formulas and BG-ranks for partitions via the Littlewood decomposition

Culturally Confounded Diagnostic Dilemmas: When Religion and Psychosis Intersect

Deregulation of miRNAs suggest the activation of a neuronal protective mechanism during preclinical stages of prion disease

The diagnostic criteria and structure of catatonia

Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice

Electroconvulsive Therapy in Managing Intractable Psychosis in Hereditary Aceruloplasminemia-Associated Neurodegeneration: A Case Report

Fabry Outcome Survey (FOS): Highlights from a 20-year patient registry of Fabry disease

Suchergebnisse filtern